<DOC>
	<DOC>NCT01033279</DOC>
	<brief_summary>The purpose of this study is to determine whether self-management of oral anticoagulation therapy with warfarin has an effect on patient's quality of life following a specific training program led by pharmacists.</brief_summary>
	<brief_title>Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy</brief_title>
	<detailed_description />
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patient aged 18 years and over followed at the Montreal Heart Institute's Anticoagulation clinic Warfarin treatment planned for at least 4 months after inclusion in the study Warfarin treatment initiated for at least 6 months Last 2 INRs between 1.5 and 4 if target INR is between 2 and 3 Last 2 INRS between 2 and 4 if target INR is between 2.5 and 3.5 Provide a signed informed consent Patient unable to understand (spoken and written) French or English Patient refuses or is unable to attend the required training sessions Targeted INR other than 2 to 3 or 2.5 to 3.5 Handicap or physical limitation compromising the patient's ability to initiate selfmonitoring in the absence of a proxy helper Moderate to severe cognitive impairment or important comprehension problems Active neoplasm Concurrent chemotherapy Hypercoagulable conditions Life expectancy of less than 1 year documented in the medical chart Inclusion (at time of inclusion or 30 days prior to inclusion) in another research project involving a drug Patient anticoagulated with nicoumalone Pregnancy or breastfeeding Active bleeding (except for menses) Recent major bleeding (less than 3 months before inclusion) Stroke, acute coronary syndrome, percutaneous coronary intervention, coronary artery bypass graft, cardiac valve replacement, deep veinous thrombosis or pulmonary embolism in the 3 months prior to inclusion Any other condition that, in the opinion of the investigators, of the treating physician or of the healthcare professionals working at the anticoagulation clinic could make selfmanagement by the patient impossible</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Coaguchek</keyword>
	<keyword>Portable coagulometer</keyword>
	<keyword>Self-monitoring</keyword>
	<keyword>Coumadin</keyword>
	<keyword>Warfarin</keyword>
	<keyword>Quality of life</keyword>
	<keyword>Pharmacist</keyword>
</DOC>